Clinical Trial Results:
A Randomised, Double-blind, Placebo-controlled, Phase 2 Study to Assess
the Efficacy and Safety of Orally Administered DS107 in a once daily dose
of 2g in Haemodialysis Patients with Moderate to Severe Uremic Pruritus
Summary
|
|
EudraCT number |
2017-004098-15 |
Trial protocol |
LV EE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
22 May 2022
|
First version publication date |
22 May 2022
|
Other versions |
|
Summary report(s) |
DS107G-04-UP1_EarlyTerm |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.